SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicenna Reports Preclinical MDNA209 Results in Autoimmune Disease Models

Medicenna reported CD122 blockade and extended survival with MDNA209 in preclinical autoimmune disease models.

MDNAF

Related stories